• Esophagogastric Cancer Patients with High DKK1 Levels Respond Better to DKN-01, Keytruda Combo, Phase 1 Trial Shows
  • INmune Bio Shares Early Results of Phase 1 Trial of INB03 for Advanced Cancer Treatment
  • ADXS-NEO Provoked Strong Immune Response in Advanced Cancer Patient, Early Trial Data Show
  • Tecentriq with Chemo Shows Promise in Untreated Advanced Urothelial Cancer
  • Trial Testing Potential Cancer Therapy THOR-707 Starts Dosing in Australia, Cleared to Enroll in U.S.
  • Upcoming Phase 2 Trial Will Test Opdivo-MTG201 Combo for Malignant Pleural Mesothelioma
  • Phase 1b Trial of Cabometyx-Tecentriq Combo in Solid Cancers Adding More Patients, Tumor Types
  • ‘Off-the-shelf’ CAR T-Cell Therapy Moving Toward 1st Clinical Trial with Takeda
  • EMA Committee Favors Keytruda-Inlyta Combo for Advanced Kidney Cancer Patients
  • FDA Grants Breakthrough Therapy Status to Lenvima-Keytruda Combo for Advanced Liver Cancer
  • ONCOS-102, Keytruda Combo May Reduce Tumor Size in Treatment-resistant Melanoma, Early Trial Data Show
  • NantKwest Launches Phase 1 Trial to Assess Investigational Cell Therapy for Solid Cancers